Risk of retinal vein occlusion in patients with systemic lupus erythematosus: A population-based cohort study

British Journal of Ophthalmology

Volumn 97, Issue 9, 2013, Pages 1192-1196

  Yen, Yung Chang ^a,b   Weng, Shih Feng ^a,c   Chen, Horng An ^a   Lin, Yung Song ^a,d  

^a Chi Mei Medical Centre   (Taiwan)

^b MIN HWEI COLLEGE OF HEALTH CARE MANAGEMENT   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EPIDEMIOLOGY; RETINA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; TAIWAN; YOUNG ADULT;

EID: 84882277508     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-303265     Document Type: Article

References (25)

1. Peponis V, Kyttaris VC, Tyradellis C, et al. Ocular manifestations of systemic lupus erythematosus: a clinical review. Lupus 2006;15:3-12.
2. Au A, O'Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Experiment Ophthalmol 2004;32:87-100.
3. Leibovitch I, Goldstein M, Loewenstein A, et al. Combined central retinal artery and vein occlusion in a patient with systemic lupus erythematosus. Rheumatology (Oxford) 2001;40:1195-6.
4. Klinkhoff AV, Beattie CW, Chalmers A. Retinopathy in systemic lupus erythematosus: relationship to disease activity. Arthritis Rheum 1986;29:1152-6.
5. Stafford-Brady FJ, Urowitz MB, Gladman DD, et al. Lupus retinopathy: patterns, associations, and prognosis. Arthritis Rheum 1988;31:1105-10.
6. Cugati S, Wang JJ, Knudtson MD, et al. Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. Ophthalmology 2007;114:520-4.
7. Kuo JZ, Lai CC, Ong FS, et al. Central retinal vein occlusion in a young Chinese population: risk factors and associated morbidity and mortality. Retina 2010;30:479-84.
8. Christoffersen N, Gade E, Knudsen L, et al. Mortality in patients with branch retinal vein occlusion. Ophthalmology 2007;114:1186-9.
9. Bandyopadhyay SK, Moulick A, Dutta A. Retinal vasculitis - an initial presentation of systemic lupus erythematosus. J Indian Med Assoc 2006;104:526-7.
10. Davies JB, Rao PK. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol 2008;19:512-18.
11. Monthermoso A, Cervera R, Font J, et al. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum 1999;28:326-32.
12. Adamczuk YP, Varela ML Iglesias, Martinuzzo ME, et al. Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis 2002;13:623-6.
13. Cheng TM. Taiwan's national health insurance system: high value for the dollar. In: Okma KGH, Crivelli L. eds. Six Countries, Six Reform Models: Their Healthcare Reform, Experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan. New Jersey: World scientific, 2009:171-204.
14. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127(8 Pt 2):757-63.
15. Gold DH, Morris DA, Henkind P. Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 1972;56:800-4.
16. Lanham JG, Barrie T, Kohner EM, et al. SLE retinopathy: evaluation by fluorescein angiography. Ann Rheum Dis 1982;41:473-8.
17. Chang ER, Pineau CA, Bernatsky S, et al. Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus. J Rheumatol 2006;33:1780-4.
18. Romero-Díaz J, García-Sosa I, Sánchez-Guerrero J. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset. J Rheumatol 2009;36:68-75.
19. Ward MM, Polisson RP. A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus. Arthritis Rheum 1989;32:1226-32.
20. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:338-46.
21. Bertelsen M, Linneberg A, Rosenberg T, et al. Comorbidity in patients with branch retinal vein occlusion: case-control study. BMJ 2012;345:e7885.
22. O'Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008;126:692-9.
23. Stem MS, Talwar N, Comer GM, et al. A Longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology 2012. doi:pii: S0161-6420(12)00743-9.
24. Aronson AJ, Ordonez NG, Diddie KR, et al. Immune-complex deposition in the eye in systemic lupus erythematosus. Arch Intern Med 1979;139:1312-13.
25. Giorgi D, Pace F, Giorgi A, et al. Retinopathy in systemic lupus erythematosus: pathogenesis and approach to therapy. Hum Immunol 1999;60:688-96.